Cumberland Pharmaceuticals INC
SEC CIK 1087294 · CPIX · last insider filing 2026-03-20
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kazimi A J | Director · Chairman and CEO | filed 2009 - 2026 |
| Brown Martin S JR | Director | filed 2022 - 2026 |
| Jones James | Director | filed 2010 - 2026 |
| Galante Joseph C | Director | filed 2018 - 2026 |
| Young Caroline | Director | filed 2016 - 2026 |
| Krogulski Kenneth | Director | filed 2017 - 2026 |
| Jacobs Joey A | Director | filed 2011 - 2023 |
| Cearnal Martin E | Director · Sr VP/Chief Commercial Officer | filed 2009 - 2022 |
| Griggs Jonathan | Director | filed 2010 - 2021 |
| Bernard Gordon R | Director · Senior Vice President | filed 2009 - 2019 |
| Lawrence Thomas R | Director | filed 2009 - 2017 |
| Edwards Robert | Director | filed 2009 - 2014 |
| Greer Lawrence W | Director | filed 2009 - 2012 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Herman James L | VP and Corporate Compliance | filed 2013 - 2026 |
| Hamm John M. | VP Chief Financial Officer | filed 2021 - 2026 |
| Bitterman Chris T. | Vice Pres Sales & Marketing | filed 2023 - 2026 |
| Anthony Todd M. | Vice Pres Organizational Dev | filed 2023 - 2026 |
| Pavliv Leo | Vice President, Operations | filed 2009 - 2022 |
| Bonner Michael | Chief Financial Officer | filed 2016 - 2021 |
| Rock Amy | See Remarks | filed 2016 - 2016 |
| Greene Rick Scott | Chief Financial Officer | filed 2011 - 2015 |
| Marstiller Jean W | Sr. VP & Corp. Secretary | filed 2009 - 2012 |
| Lowrance David L | Vice President and CFO | filed 2009 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.